San Francisco, California, United States
Proven consultant and trainer in leading Clinical Molecular Diagnostic labs to go live in an exceptionally dynamic sales environment, while establishing the highest quality of client relationships. • Subject Matter Expert in molecular SARS-CoV-2 EUA testing to facilitate the detection of Coronavirus (COVID-19). • Subject Matter Expert in high-throughput automation (Personalized Medicine and Cystic Fibrosis IVD). • Emphasis on driving a consultative selling process to ensure customer adoption of Molecular Dx assays, while generating additional revenue growth through new product lines. • Successfully contributed to the launch of 5 new IVD technologies and 20 assays.
Consistently demonstrate the ability to thrive in a high pressure and competitive environment with an intense drive to succeed. This approach combines in-depth scientific knowledge and strategic selling savvy to stay ahead of the curve in an ever changing market space. • Specializing in data acquisition and software analysis for Pharmacogenetics & Infectious Disease. • Expert in FDA-approved Multiplex (xTAG), ARIES, and MultiCode-RTx assays, Nanosphere Verigene, and their competitive counterparts. • Close partner with Clinical Trials, Regional Marketing, and R&D in the positioning of new technologies as they are launched. • Well practiced in the regulated LDT environment.
Elucidated Craniofacial Development (Cleft lip) with a Novel Mutant Mouse Line. Dept. of Pathology and Lab Medicine
Preparation of Gene Expression/Cloning Plasmids for the Secretome Project. Part of a High-throughput receptor-ligand screening platform targeting therapeutic intervention. Depts. of Molecular Biology and Assay/Automation Technology
CIMERA The Center for Interdisciplinary Molecular Biology: Education, Research and Advancement.